Genedrive (LSE:GDR) Buyback Yield %: -3.96 (As of Jul. 13, 2026)


What is Genedrive Buyback Yield %?

Genedrive LSE:GDR +4.08% Buyback Yield % is -3.96 as of Jul. 13, 2026. The stock has 4 warning signs investors should review. Among 90 Medical Diagnostics & Research companies, Genedrive ranks worse than 53.33% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Genedrive's current buyback yield was -3.96%.

Genedrive Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Genedrive's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genedrive Buyback Yield % Chart

Genedrive Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -43.95 -9.61 -66.18 -13.85

Genedrive Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -66.18 0.00 -13.85 -8.89

LSE:GDR vs TMO, DHR, IDXX: Buyback Yield % Comparison

For the Diagnostics & Research subindustry, Genedrive's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genedrive Buyback Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genedrive's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Genedrive's Buyback Yield % falls into.


Genedrive Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Genedrive's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.226) / 8.850702
=-13.85%

Genedrive's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.81) / 9.11425375
=-8.89%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -3.96 mean?
Genedrive (LSE:GDR) has a Buyback Yield % of -3.96 as of Jul. 13, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Genedrive and its competitors. According to the industry distribution chart, Genedrive ranks #48 out of 90 companies in the Medical Diagnostics & Research industry, placing it in the top 53.3%.
Is Genedrive's Buyback Yield % too high?
Genedrive's current Buyback Yield % is -3.96. Based on the distribution chart, Genedrive ranks #48 out of 90 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does Genedrive's Buyback Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Genedrive ranks #48 out of 90 companies for Buyback Yield %. This places Genedrive in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Diagnostics & Research company?
A good Buyback Yield % depends on the Medical Diagnostics & Research industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Genedrive and its competitors. Genedrive's current Buyback Yield % is -3.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genedrive stock overvalued right now?
Genedrive (LSE:GDR) has a current Buyback Yield % of -3.96. The current Buyback Yield % is -3.96. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Genedrive (LSE:GDR), the current Buyback Yield % is -3.96 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genedrive Business Description

Other Exchanges D6M:Germany
Address Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States of America and Rest of the World.